Hansa Biopharma — Januar 2023
-
-
Ja, tak for godmorgen hilsnerne LP90.: Her lidt ekstra nyt. Det er den første lungetransplantation hvor Imlifidase er benyttet. Det er Off-Label, så Hansa kan ikke selv promovere casen https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.amjtransplant.org%2Farticle%2FS1600-6135(22)29297-1%2Ffulltext&data=05|01|klaus.sindahl%40hansabiopharma.com|4f247279a504470b0d9208daee56ce69|2baeedcdecb6405a84aaec90b3dbc240|0|0|638084354332097185|Unknown|TWFpbGZsb3d8eyJWIjoiM
-
Flot
stigning igen, på en lidt sur dag….spændende hvornår den skal have tæsk igen
-
Vildt som den fortsætter med at gå imod markedet
Noget har ændret sig i det nye år, for i 2022 skulle den nok falde som en sten når markedet var negativt. Mon nogen der ved noget?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind